Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosella Mechelli

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Journal of Autoimmunity|May 4, 2019
A cell type-specific transcriptomic approach to map B cell and monocyte type I interferon-linked pathogenic signatures in Multiple SclerosisMartina Severa, Fabiana Rizzo, Sundararajan Srinivasan, et al.
Frontiers in Neurology|September 13, 2021
Intestinal Permeability and Circulating CD161+CCR6+CD8+T Cells in Patients With Relapsing-Remitting Multiple Sclerosis Treated With DimethylfumarateMaria C Buscarinu, Francesca Gargano, Luana Lionetto, et al.
Annals of Neurology|December 15, 2018
DNA damage signatures in peripheral blood cells as biomarkers in prodromal huntington diseaseImma Castaldo, Mariarosaria De Rosa, Antonella Romano, et al.
International Journal of Molecular Sciences|October 27, 2022
Circulating U13 Small Nucleolar RNA as a Potential Biomarker in Huntington's Disease: A Pilot StudySilvia Romano, Carmela Romano, Martina Peconi, et al.
Journal of Neuroimmunology|October 2, 2018
Analysis of coding and non-coding transcriptome of peripheral B cells reveals an altered interferon response factor (IRF)-1 pathway in multiple sclerosis patientsViviana Annibali, Renato Umeton, Antonia Palermo, et al.
Journal of Medical Genetics|March 29, 2011
Association of HLA class I markers with multiple sclerosis in the Italian and UK population: evidence of two independent protective effectsLaura Bergamaschi, Maria Ban, Nadia Barizzone, et al.
Journal of Autoimmunity|February 13, 2026
Multiple sclerosis-associated EBNA2 variants influence the response to peginterferon beta-1a therapyCaterina Veroni, Fortunata Carbone, Daniela Ricci, et al.
Neurology|March 6, 2015
Epstein-Barr virus genetic variants are associated with multiple sclerosisRosella Mechelli, Caterina Manzari, Claudia Policano, et al.
Frontiers in Immunology|August 18, 2022
Proinflammatory mucosal-associated invariant CD8+ T cells react to gut flora yeasts and infiltrate multiple sclerosis brainFrancesca Gargano, Gisella Guerrera, Eleonora Piras, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 4, 2025
A disease-specific convergence of host and Epstein-Barr virus genetics in multiple sclerosisRosella Mechelli, Renato Umeton, Gianmarco Bellucci, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Journal of Autoimmunity|May 4, 2019
A cell type-specific transcriptomic approach to map B cell and monocyte type I interferon-linked pathogenic signatures in Multiple SclerosisMartina Severa, Fabiana Rizzo, Sundararajan Srinivasan, et al.
Frontiers in Neurology|September 13, 2021
Intestinal Permeability and Circulating CD161+CCR6+CD8+T Cells in Patients With Relapsing-Remitting Multiple Sclerosis Treated With DimethylfumarateMaria C Buscarinu, Francesca Gargano, Luana Lionetto, et al.
Annals of Neurology|December 15, 2018
DNA damage signatures in peripheral blood cells as biomarkers in prodromal huntington diseaseImma Castaldo, Mariarosaria De Rosa, Antonella Romano, et al.
International Journal of Molecular Sciences|October 27, 2022
Circulating U13 Small Nucleolar RNA as a Potential Biomarker in Huntington's Disease: A Pilot StudySilvia Romano, Carmela Romano, Martina Peconi, et al.
Journal of Neuroimmunology|October 2, 2018
Analysis of coding and non-coding transcriptome of peripheral B cells reveals an altered interferon response factor (IRF)-1 pathway in multiple sclerosis patientsViviana Annibali, Renato Umeton, Antonia Palermo, et al.
Journal of Medical Genetics|March 29, 2011
Association of HLA class I markers with multiple sclerosis in the Italian and UK population: evidence of two independent protective effectsLaura Bergamaschi, Maria Ban, Nadia Barizzone, et al.
Journal of Autoimmunity|February 13, 2026
Multiple sclerosis-associated EBNA2 variants influence the response to peginterferon beta-1a therapyCaterina Veroni, Fortunata Carbone, Daniela Ricci, et al.
Neurology|March 6, 2015
Epstein-Barr virus genetic variants are associated with multiple sclerosisRosella Mechelli, Caterina Manzari, Claudia Policano, et al.
Frontiers in Immunology|August 18, 2022
Proinflammatory mucosal-associated invariant CD8+ T cells react to gut flora yeasts and infiltrate multiple sclerosis brainFrancesca Gargano, Gisella Guerrera, Eleonora Piras, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 4, 2025
A disease-specific convergence of host and Epstein-Barr virus genetics in multiple sclerosisRosella Mechelli, Renato Umeton, Gianmarco Bellucci, et al.
Pageof 5